Meghana Keshavan

Meghana Keshavan

Meghana has spent the last year-and-a-half writing about biotech and healthcare for the San Diego Business Journal. Previously, she's worked for Reuters, Crain’s Detroit Business, the Detroit Free Press and WDET, a Detroit-based National Public Radio affiliate. Meghana studied biochemistry and molecular biology at Penn State University and spent five years as a self-described "research peon in a schizophrenia genetics lab."

Follow Meghana Keshavan: Twitter |


Venture perspectives on the venture climate: #CEDLSC15

Venture perspectives on the venture climate: #CEDLSC15

March 4, 2015 7:02 pm by | 0 Comments

Venture funding’s contracting – so are investors making any innovative moves to keep life sciences companies flush with needed cash? This idea was addressed at this week’s panel discussion at the…


The secret sauce of venture philanthropy: Passion and forced collaboration #CEDLSC15

The secret sauce of venture philanthropy: Passion and forced collaboration #CEDLSC15

March 4, 2015 6:30 am by | 0 Comments

Last fall, all eyes darted to the concept of venture philanthropy – using venture dollars to empower patient advocacy efforts – when the Cystic Fibrosis Foundation sold its royalty rights to the Vertex…



Still valid? Here’s Herb Boyer’s $500 check that helped launch Genentech #CEDLSC15

Still valid? Here’s Herb Boyer’s $500 check that helped launch Genentech #CEDLSC15

March 3, 2015 4:31 pm by | 1 Comments

Genentech cofounder Herb Boyer told his origin story at this week’s CED Life Sciences conference in Raleigh. He waxed nostalgic about carefree, football-playing days in Western Pennsylvania – as well as his role in the genesis of…


Angel investor involvement growing in North Carolina life sciences startup scene #CEDLSC15

Angel investor involvement growing in North Carolina life sciences startup scene #CEDLSC15

March 3, 2015 10:51 am by | 0 Comments

Angels and high net-worth individuals are making up a growing investment base for North Carolina’s startup sector – an interesting trend that shows that venture dollars are losing their pull…


NIH workshop starts fleshing out details of Obama’s Precision Medicine Initiative

NIH workshop starts fleshing out details of Obama’s Precision Medicine Initiative

February 19, 2015 6:41 pm by | 0 Comments

There’s been much hype around President Obama’s Precision Medicine Initiative, but how realistic is it to execute successfully? A number of scientists and patient advocates met for an NIH workshop last week…


Chief Data Scientist DJ Patil knows data. But does he know healthcare?

Chief Data Scientist DJ Patil knows data. But does he know healthcare?

February 19, 2015 5:57 pm by | 4 Comments

DJ Patil is a smart guy who knows data – and he’ll play a key role in President Obama’s Precision Medicine Initiative. But what the White House’s first-ever Chief Data Scientist is short…


Vascular Therapies raises $16.2M for hemodialysis transplant work

Vascular Therapies raises $16.2M for hemodialysis transplant work

February 19, 2015 3:54 pm by | 0 Comments

New Jersey medical device maker Vascular Therapies just raised $16.2 million of a potential $27 million, according to a regulatory filing. The funding comes from 30 investors. The company’s kept…



Bringing blood irradiation back en vogue: Startup uses UV phototherapy treat infections in the bloodstream

Bringing blood irradiation back en vogue: Startup uses UV phototherapy treat infections in the bloodstream

February 18, 2015 6:24 pm by | 0 Comments

Diseased cells circulate around our bloodstream, which allows their spread throughout our bodies. What if there were a way to filter out the bad cells while letting the good ones thrive? Santa…


MiRagen raises $8.5 million for microRNA therapies that treat heart and blood disorders

MiRagen raises $8.5 million for microRNA therapies that treat heart and blood disorders

February 18, 2015 3:19 pm by | 0 Comments

Colorado-based MicroRNA upstart MiRagen Therapeutics just raised $8.5 million of a potential $20 million round, according to a regulatory filing. Its miRNA drugs are focused on correcting a number of cardiovascular,…


Breathe Technologies ventilation devices lighten the load for patients with COPD and other breathing disorders

Breathe Technologies ventilation devices lighten the load for patients with COPD and other breathing disorders

February 18, 2015 1:19 pm by | 0 Comments

Staying stationary is one of the worst ways to exacerbate a breathing disorder – without activity and exercise, patients with conditions like COPD, interstitial lung disease and in need of…


New anorexia treatment in the works? Cambridge startup gets $28.3M to develop biologics that restore homeostasis

New anorexia treatment in the works? Cambridge startup gets $28.3M to develop biologics that restore homeostasis

February 17, 2015 8:21 pm by | 0 Comments

Biologics are typically used as therapeutics, but a Cambridge startup is using precise protein chemistry to move the field a little closer to the nutraceutical space. Pronutria‘s biologics are meant to…


Crutches that prevent underarm strain: BetterWalk raises Series A

Crutches that prevent underarm strain: BetterWalk raises Series A

February 17, 2015 12:40 pm by | 0 Comments

One of the worst parts of hobbling around on crutches? That searing pressure-pain under your arms. Atlanta medical device company BetterWalk says it has a fix for that – it’s…


Arcturus emerging as a strong player in RNA therapeutics space

Arcturus emerging as a strong player in RNA therapeutics space

February 14, 2015 8:00 am by | 0 Comments

With a fast-growing pipeline of siRNA and mRNA drugs, San Diego startup Arcturus Therapeutics is poised join the ranks of more established RNA-based drug companies like Alnylam and Moderna Therapeutics. It’s welcome timing, as the market’s cast a…


How illuminating: Invuity raises $20M for its surgical tools that light up

How illuminating: Invuity raises $20M for its surgical tools that light up

February 13, 2015 1:20 pm by | 0 Comments

Invuity, a Bay Area medtech that builds surgical tools to help illuminate a patient’s innards during an operation, just raised $20 million in equity. The new dollars will help Invuity up commercialization efforts across…


UNC spinout looking to one-up Kalydeco with one-size-fits-all cystic fibrosis therapy

UNC spinout looking to one-up Kalydeco with one-size-fits-all cystic fibrosis therapy

February 13, 2015 6:00 am by | 0 Comments

Cystic fibrosis has become the poster child for precision medicine – most new therapies are carefully tailored to a CF patient’s genetic makeup. University of North Carolina spinout Spyryx Biosciences is proposing…